Percentage of CD107a expression in NK cells from 43 controls and 36 HLH patients. (DOCX 15 kb
Figure S4. ROC curve of the plasma levels of cytokines and T-cell characteristics in H7N9 patients. ...
Supplemental Table 1 provides a full list of differentially expressed (2-fold or greater) genes fr...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Scatterplot of NK cell cytotoxic activity, displayed as lytic units at 25 % specific lysis, and freq...
Sequencing results of STXBP2 gene. Two mutations of STXBP2 gene, c.575G>A (p.Arg192His) in P10, and ...
Key immunogenic and immunomodulatory molecules after 3 days of in vitro treatment of ucMSC. The tabl...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Flow cytometric analysis of NK cell purity. NK cells were gated in the FSC/SSC on the lymphocyte gat...
Table S1. List of tissues and cell types. Table S2. Median HLA expression values of the GTEx and HPA...
Figure S7. RNA-seq analysis of cytokine expression in plasmacytoid dendritic cells stimulated for 6Â...
Table S1. Individual data on treatment, responsiveness, NK cell counts per μl blood, and frequencies...
Immunological variables (in CD4 and CD8 T-cell subsets) with significant differences between EC pati...
Distribution of all variants (a) and variants with likely pathogenic effect (b) by gene. Frequency o...
Flow diagram showing the inclusion criteria and the sequential strategy for selecting the patients i...
Figure S4. ROC curve of the plasma levels of cytokines and T-cell characteristics in H7N9 patients. ...
Supplemental Table 1 provides a full list of differentially expressed (2-fold or greater) genes fr...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
Scatterplot of NK cell cytotoxic activity, displayed as lytic units at 25 % specific lysis, and freq...
Sequencing results of STXBP2 gene. Two mutations of STXBP2 gene, c.575G>A (p.Arg192His) in P10, and ...
Key immunogenic and immunomodulatory molecules after 3 days of in vitro treatment of ucMSC. The tabl...
Table S4. Proportion of positive cells by CD27 expression status. Proportion of CD27+ B cells, CD27-...
Table S5. MFI of PD-1, PD-L1 and PD-L2 on CD27+ B cells, CD27- B cells, CD27+ CD4+ T cells and CD27-...
Flow cytometric analysis of NK cell purity. NK cells were gated in the FSC/SSC on the lymphocyte gat...
Table S1. List of tissues and cell types. Table S2. Median HLA expression values of the GTEx and HPA...
Figure S7. RNA-seq analysis of cytokine expression in plasmacytoid dendritic cells stimulated for 6Â...
Table S1. Individual data on treatment, responsiveness, NK cell counts per μl blood, and frequencies...
Immunological variables (in CD4 and CD8 T-cell subsets) with significant differences between EC pati...
Distribution of all variants (a) and variants with likely pathogenic effect (b) by gene. Frequency o...
Flow diagram showing the inclusion criteria and the sequential strategy for selecting the patients i...
Figure S4. ROC curve of the plasma levels of cytokines and T-cell characteristics in H7N9 patients. ...
Supplemental Table 1 provides a full list of differentially expressed (2-fold or greater) genes fr...
Figure S3. B cell percentage positivity. Comparison of the expression levels as determined by percen...
DOI
Add to ORKG